Tuesday, October 02, 2012 8:29:16 PM
TSRO. TESARO Announces Clearance of Investigational New Drug Application for TSR-011
Company Plans to Proceed With a Phase 1/2 Clinical Study of the Anaplastic Lymphoma Kinase (ALK) Inhibitor TSR-011
http://finance.yahoo.com/news/tesaro-announces-clearance-investigational-drug-203000058.html
Company Plans to Proceed With a Phase 1/2 Clinical Study of the Anaplastic Lymphoma Kinase (ALK) Inhibitor TSR-011
http://finance.yahoo.com/news/tesaro-announces-clearance-investigational-drug-203000058.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
